Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Trial of Epoetin Alfa in Men With Hormone-refractory Prostate Cancer and Anemia.

NCT00364455 is registered in ClinicalTrials.gov with Janssen-Ortho Inc., Canada as lead sponsor.

NCT NCT00364455
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00364455 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Trial of Epoetin Alfa in Men With Hormone-refractory Prostate Cancer and Anemia.
Lead sponsor
Janssen-Ortho Inc., Canada
Phase
Phase 3
Overall status
Completed
Start date
December 31, 2002
Completion date
March 31, 2006
Enrollment
56 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

carcinoma, prostate